SCHEMBL606019

SCHEMBL606019

c1ccc2c(c1)sc1cncnc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 3/20 0.50
CDK5 Q00535 1/20 0.50
CDK5R1 Q15078 1/20 0.50
GPR3 P46089 1/20 0.48
EGFR P00533 5/20 0.41
HTR2C P28335 1/20 0.40
HRH4 Q9H3N8 1/20 0.40
PIK3CA P42336 1/20 0.39
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GABRA1 P14867 2/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20496936 0.85 SMN1; SMN2 (0.40) LIMK1CDK5CDK5R1GPR3EGFR
SCHEMBL22483133 0.81 KDM4E (0.36) LIMK1CDK5CDK5R1ALDH1A1HPGD
SCHEMBL22483136 0.79 CYP2A6 (0.33) LIMK1CDK5CDK5R1
SCHEMBL22483175 0.79 EGFR (0.39) LIMK1CDK5CDK5R1EGFRPIK3CA
SCHEMBL17917464 0.79 EGFR (0.31) LIMK1EGFR
SCHEMBL24624428 0.78 LIMK1 (0.37) LIMK1CDK5CDK5R1HTR2CALDH1A1
SCHEMBL22483140 0.77 LIMK1 (0.53) LIMK1CDK5CDK5R1EGFRALDH1A1
SCHEMBL2855389 0.77 CLK1 (0.51) LIMK1EGFRPIK3CA
SCHEMBL19758403 0.76 LIMK1 (0.40) LIMK1CDK5CDK5R1GPR3EGFR
SCHEMBL22483132 0.76 LIMK1 (0.40) LIMK1CDK5CDK5R1EGFRHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1810 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12622132-B2 Light-emitting device, light-emitting apparatus, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2026-05-05 US claimed
US-12559671-B2 Light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2026-02-24 US claimed
US-12473297-B2 Heterocyclic compound and organic light emitting diode comprising same LT MATERIALS CO., LTD. (KR) 2025-11-18 US claimed
US-12457894-B2 Organometallic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2025-10-28 US claimed
US-20250257089-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO. LTD. (KR) 2025-08-14 US claimed
US-20250204248-A1 Organic Compound And Light-Emitting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-06-19 US claimed
CN-120157700-A Organic compound and light-emitting device 株式会社半导体能源研究所 2025-06-17 CN claimed
US-12324349-B2 Organometallic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2025-06-03 US claimed
US-12289985-B2 Organic light-emitting device, apparatus including the same, and organometallic compound SAMSUNG DISPLAY CO., LTD. (KR) 2025-04-29 US claimed
WO-2025023698-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 진웅산업 2025-01-30 WO claimed
US-20160351818-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-12-01 US claimed
US-20160351817-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2016-12-01 US claimed
EP-3098873-A1 ORGANIC LIGHT-EMITTING DEVICE Samsung Display Co., Ltd. (KR) 2016-11-30 EP claimed
US-20160013421-A1 Light-Emitting Element, Compound, Display Module, Lighting Module, Light-Emitting Device, Display Device, Lighting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-01-14 US claimed
US-20150333273-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-11-19 US claimed
US-20130202685-A1 Use of a histamine H4 antagonist for the treatment of post-operative adhesions JANSSEN PHARMACEUTICA NV (US) 2013-08-08 US claimed
JP-2011524361-A 2011-09-01 JP claimed
US-20110076324-A1 Use of Histamine H4 antagonist for the treatment of post-operative adhesions JANSSEN PHARMACEUTICA NV (BE) 2011-03-31 US claimed
EP-2291197-A1 USE OF HISTAMINE H4 ANTAGONIST FOR THE TREATMENT OF POST-OPERATIVE ADHESIONS Janssen Pharmaceutica, N.V. (BE) 2011-03-09 EP claimed
WO-2009152287-A1 USE OF HISTAMINE H4 ANTAGONIST FOR THE TREATMENT OF POST-OPERATIVE ADHESIONS JANSSEN PHARMACEUTICA NV (BE) 2009-12-17 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12622132-B2 Light-emitting device, light-emitting apparatus, electronic device, and lighting device CYBA, NFE2L2, AOX1 LIMK1 125/4885CDK5 4545/4885CDK5R1 4404/4885
US-20160013421-A1 Light-Emitting Element, Compound, Display Module, Lighting Module, Light-Emitting Device, Display Device, Lighting Device, and Electronic Device TPMT, DPYD, HPRT1 LIMK1 226/4885CDK5 2077/4885CDK5R1 3139/4885
US-12289985-B2 Organic light-emitting device, apparatus including the same, and organometallic compound LEF1, OCIAD1, OXA1L LIMK1 36/4885CDK5 4120/4885CDK5R1 3940/4885
US-20150333273-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CRY2 LIMK1 1035/4885CDK5 315/4885CDK5R1 514/4885
US-20250204248-A1 Organic Compound And Light-Emitting Device TPMT, PAICS, TYMS LIMK1 582/4885CDK5 314/4885CDK5R1 721/4885
US-12457894-B2 Organometallic compound and organic light-emitting device including the same CRY1, OCIAD1, ORC3 LIMK1 215/4885CDK5 3177/4885CDK5R1 3380/4885
US-12559671-B2 Light-emitting device SCO2, GRIN2C, GLRA2 LIMK1 993/4885CDK5 934/4885CDK5R1 478/4885
US-20250257089-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME MT-CO1, OXA1L, CRY1 LIMK1 89/4885CDK5 2397/4885CDK5R1 2517/4885
US-12473297-B2 Heterocyclic compound and organic light emitting diode comprising same CRY1, CYP1B1, CYP1A1 LIMK1 759/4885CDK5 680/4885CDK5R1 1054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.